Rapid and dramatic radiographic and clinical response to an ALK inhibitor (crizotinib, PF02341066) in an ALK translocation-positive patient with non-small cell lung cancer.
暂无分享,去创建一个
Jeffrey W. Clark | A. Iafrate | S. Ou | A. Shaw | Y. Bang | R. Salgia | K. Wilner | B. Solomon | R. Maki | D. Camidge | E. Kwak | L. Bazhenova | Tatiana Kain | June Herman | Robert G. Maki